30 days of immunotherapy education and awareness programming for patients, caregivers, and the others celebrating advances in immuno-oncology research and treatment
Report reveals that the cellular immunotherapy landscape continues to expand, with 472 more cellular therapies in development now than one year ago.
Results of recent survey of clinical trial investigators in United States, Europe, and Asia together with analysis of ongoing clinical trials conducted by IQVIA published in Nature Reviews Drug Discovery.
The American Association for Cancer Research (AACR) will present Steven A. Rosenberg, MD, PhD, Fellow of the AACR Academy, with the 2020 AACR-CRI Lloyd J. Old Award in Cancer Immunology.
Updated report on trends in global PD-1/PD-L1 immunotherapy clinical development from the Cancer Research Institute published in Nature Reviews Drug Discovery.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This April for Esophageal Cancer Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to esophageal cancer.
Spring equinox marks a moment of renewal. Why not choose a personal goal to invest in yourself and the world around you? Join ’21 Challenge for Cancer Research.